From: Reliability of the Siemens Enzygnost and Novagnost Epstein–Barr Virus assays for routine laboratory diagnosis: agreement with clinical diagnosis and comparison with the Merifluor Epstein–Barr Virus immunofluorescence assay
Enzygnost interpretation
Negative
Acute infection
Past infection
Indeterminate
% agreement with EBV status
EBV status
Negative (N = 39)
39
0
100
Acute infection (N = 15)
15
Past infection (N = 464)
2
460
99.1